Skyline Therapeutics

Skyline Therapeutics is a dynamic, fully integrated gene and cell therapy company focused on the discovery, development, and delivery of groundbreaking therapies. Committed to transforming patient outcomes, Skyline Therapeutics leverages cutting-edge genetic science to address devastating diseases and improve lives worldwide.

With a world-class team of experts at the helm, Skyline Therapeutics has pioneered a proprietary AAV gene therapy platform. This platform integrates novel capsid engineering, advanced vector design, analytical and process development, and state-of-the-art GMP manufacturing capabilities. These advanced capabilities ensure large-scale production of clinical-grade vectors, supporting the company's mission to deliver innovative solutions.

Skyline Therapeutics is dedicated to advancing a diverse pipeline of programs targeting serious diseases through disruptive gene and cell therapy approaches. The company is rapidly expanding its reach and impact in the pharmaceutical industry. We invite the management team at Skyline Therapeutics to create a customized and exclusive company showcase and product listing on our platform, highlighting their unique contributions to the field.